Aptamer‐Engineered Ellipsometry for Clinical Detection of BALF‐Derived Exosomes: Multi‐Level Engineering for Prognostic Evaluation of Immunotherapy Responses
Advanced Science · 2026
DOI: 10.1002/advs.202515247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Euna Jeong und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences and Bioengineering, Inha University, Incheon, 22212, Republic of Korea. Hauptthemen laut MEDLINE: Exosomes, Immunotherapy, Bronchoalveolar Lavage Fluid, Aptamers, Nucleotide. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF), Ministry of Science and ICT, Korean Fund for Regenerative Medicine.
Abstract (Originalsprache)
Exosomes emerges as indicators of the tumor microenvironment, yet their predictive utility for immunotherapy responses is limited by the insufficient sensitivity and specificity of currently available assays. Here, a multi‐level engineering strategy is presented that enables accurate exosome‐based prediction of immunotherapy responses by integrating systematic aptamer ligand tailoring, ultrasensitive ellipsometry‐based sensing, and clinically relevant tumor‐proximal fluid sampling. Aptamers specifically targeting PD‐L1 are identified through systematic evolution of ligands by exponential enrichment (SELEX), followed by truncation and computational sequence refinement to enhance binding specificity. The optimized aptamer sequence (Tr‐Apt13) is validated from molecular interaction analyses to in vitro assays, demonstrating superior target binding efficacy over conventional antibodies, attributed to dense surface immobilization and multivalent binding capability. When incorporated into an ellipsometry‐based dual‐prism solution‐immersed silicon sensor, Tr‐Apt13 enabled ultrasensitive detection of PD‐L1–expressing exosomes with a detection limit of ≈9.8 particles mL −1 , exhibiting high linearity and stability. Clinical validation using bronchoalveolar lavage fluid (BALF) from lung cancer patients revealed precise discrimination between responders and non‐responders at exosome concentrations as low as 10 3 particles mL −1 , outperforming serum‐based analysis, conventional ELISA, and tissue immunohistochemistry. Collectively, this multi‐level strategy offers a new perspective on exosome‐based diagnostics, enabling precise prediction of immunotherapy efficacy in lung cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences and Bioengineering, Inha University, Incheon, 22212, Republic of Korea.
- Division of Biomedical Metrology, Korea Research Institute of Standards and Science, Daejeon, 34113, Republic of Korea.
- Department of Chemical Engineering, Kwangwoon University, Seoul, 01897, Republic of Korea.
- Division of Pulmonology, Department of Internal Medicine, Inha University Hospital, Inha University College of Medicine, Incheon, 22332, Republic of Korea.
- Department of Pathology, Inha University Hospital, Inha University College of Medicine, Incheon, 22332, Republic of Korea.
- Strategic Technology Research Institute, Korea Research Institute of Standards and Science, Daejeon, 34113, Republic of Korea.
Förderung
- National Research Foundation of Korea (NRF)
- Ministry of Science and ICT
- Korean Fund for Regenerative Medicine
- Korea Technology & Information Promotion Agency for SMEs
- National Research Council of Science and Technology
- Korea Research Institute of Standards and Science
- Materials & Components Technology Development Program
- Ministry of Trade Industry & Energy(MOTIE, Korea)
Zitieren
APA
Jeong, E., Choi, J. H., Lee, M., Lim, J. H., Jung, S., Woo, Y., Kim, J. Y., Ok, J., Kim, L., Jeong, W. J., Chegal, W., Cho, H. M., Park, C., Bu, J., Kim, D. H., & Lee, T. (2026). Aptamer‐Engineered Ellipsometry for Clinical Detection of BALF‐Derived Exosomes: Multi‐Level Engineering for Prognostic Evaluation of Immunotherapy Responses. Advanced Science. https://doi.org/10.1002/advs.202515247
Vancouver
Jeong E, Choi JH, Lee M, Lim JH, Jung S, Woo Y, et al. Aptamer‐Engineered Ellipsometry for Clinical Detection of BALF‐Derived Exosomes: Multi‐Level Engineering for Prognostic Evaluation of Immunotherapy Responses. Advanced Science. 2026. doi:10.1002/advs.202515247
BibTeX
@article{Jeong2026,
author = {Jeong, Euna and Choi, Jung Hyun and Lee, Minyoung and Lim, Jun Hyeok and Jung, Seokho and Woo, Yeeun and Kim, Joo-Young and Ok, Jaehyeon and Kim, Lucia and Jeong, Woo-Jin and Chegal, Won and Cho, Hyun Mo and Park, Chulhwan and Bu, Jiyoon and Kim, Dong Hyung and Lee, Taek},
title = {Aptamer‐Engineered Ellipsometry for Clinical Detection of BALF‐Derived Exosomes: Multi‐Level Engineering for Prognostic Evaluation of Immunotherapy Responses},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202515247}
}
EUVIMED